441 related articles for article (PubMed ID: 33164947)
1. The issues of individualized medicine and pharmacovigilance: A consideration of COVID-19 and vaccination.
Ralph Edwards I; Lindquist M
Int J Risk Saf Med; 2020; 31(4):179-180. PubMed ID: 33164947
[No Abstract] [Full Text] [Related]
2. COVID19 meets the antivaccine movement.
Hotez PJ
Microbes Infect; 2020; 22(4-5):162-164. PubMed ID: 32442682
[No Abstract] [Full Text] [Related]
3. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
[No Abstract] [Full Text] [Related]
4. [COVID-19 vaccines increase the risk of anaphylaxis].
Alnæs M; Storaas T; Sørensen M; Stylianou E; Tøndell A
Tidsskr Nor Laegeforen; 2021 Mar; 141(4):. PubMed ID: 33685103
[No Abstract] [Full Text] [Related]
5. Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines.
Schulze-Koops H; Specker C; Skapenko A
RMD Open; 2021 Feb; 7(1):. PubMed ID: 33627439
[TBL] [Abstract][Full Text] [Related]
6. Messengers of hope.
Nat Biotechnol; 2021 Jan; 39(1):1. PubMed ID: 33376248
[TBL] [Abstract][Full Text] [Related]
7. Equitable access to COVID-19 vaccination: a distant dream?
Lomazzi M; De Sousa L; Amofah G; Ricciardi W
Eur J Public Health; 2020 Dec; 30(6):1039-1040. PubMed ID: 33027515
[No Abstract] [Full Text] [Related]
8. Status of vaccine development for COVID-19.
Mendes A
Br J Community Nurs; 2020 Dec; 25(12):620-621. PubMed ID: 33275511
[No Abstract] [Full Text] [Related]
9. Tackling inequitable distribution of the COVID-19 vaccine.
Mendes A
Br J Community Nurs; 2021 Jan; 26(1):48-49. PubMed ID: 33356933
[No Abstract] [Full Text] [Related]
10. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
Kahn JP; Henry LM; Mastroianni AC; Chen WH; Macklin R
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28538-28542. PubMed ID: 33122444
[No Abstract] [Full Text] [Related]
11. The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials.
Rid A; Lipsitch M; Miller FG
JAMA; 2021 Jan; 325(3):219-220. PubMed ID: 33315080
[No Abstract] [Full Text] [Related]
12. Myocarditis Temporally Associated With COVID-19 Vaccination.
Rosner CM; Genovese L; Tehrani BN; Atkins M; Bakhshi H; Chaudhri S; Damluji AA; de Lemos JA; Desai SS; Emaminia A; Flanagan MC; Khera A; Maghsoudi A; Mekonnen G; Muthukumar A; Saeed IM; Sherwood MW; Sinha SS; O'Connor CM; deFilippi CR
Circulation; 2021 Aug; 144(6):502-505. PubMed ID: 34133885
[TBL] [Abstract][Full Text] [Related]
13. Indirect benefits are a crucial consideration when evaluating SARS-CoV-2 vaccine candidates.
Gallagher ME; Sieben AJ; Nelson KN; Kraay ANM; Orenstein WA; Lopman B; Handel A; Koelle K
Nat Med; 2021 Jan; 27(1):4-5. PubMed ID: 33230343
[No Abstract] [Full Text] [Related]
14. Why Oxford's positive COVID vaccine results are puzzling scientists.
Callaway E
Nature; 2020 Dec; 588(7836):16-18. PubMed ID: 33230278
[No Abstract] [Full Text] [Related]
15. Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing.
Fischer JC; Schmidt AG; Bölke E; Keitel V; Feldt T; Jensen B; Freise NF; Häussinger D; Schneider EM; Hermsen D; Kindgen-Milles D; Knoefel WT; Haussmann J; Tamaskovics B; Plettenberg C; Scheckenbach K; Corradini S; Rox J; Balz V; Maas K; Schmidt L; Grebe O; Ehrhardt A; Gerber PA; Peiper M; Buhren BA; Lichtenberg A; Rezazadeh A; Budach W; Matuschek C
Eur J Med Res; 2021 Aug; 26(1):87. PubMed ID: 34362461
[TBL] [Abstract][Full Text] [Related]
16. Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-2.
Book BAJ; Schmidt B; Foerster AMH
JAMA Ophthalmol; 2021 Jul; 139(7):e212471. PubMed ID: 34287612
[No Abstract] [Full Text] [Related]
17. Myocarditis After BNT162b2 and mRNA-1273 Vaccination.
Larson KF; Ammirati E; Adler ED; Cooper LT; Hong KN; Saponara G; Couri D; Cereda A; Procopio A; Cavalotti C; Oliva F; Sanna T; Ciconte VA; Onyango G; Holmes DR; Borgeson DD
Circulation; 2021 Aug; 144(6):506-508. PubMed ID: 34133884
[TBL] [Abstract][Full Text] [Related]
18. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted.
Med Lett Drugs Ther; 2021 May; 63(1624):e1. PubMed ID: 33976095
[No Abstract] [Full Text] [Related]
19. The UK has approved a COVID vaccine - here's what scientists now want to know.
Ledford H; Cyranoski D; Van Noorden R
Nature; 2020 Dec; 588(7837):205-206. PubMed ID: 33288887
[No Abstract] [Full Text] [Related]
20. Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
Rubin EJ; Baden LR; Barocas JA; Morrissey S
N Engl J Med; 2020 Dec; 383(24):e143. PubMed ID: 33296567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
